#Genetic Testing

DNA and genetic screening tests for assessing hereditary disease risk.

Diagnostics

GenEra NIPT – “Panorama”, standard

Non-invasive prenatal test (NIPT) from the mother's blood, which determines the risk of chromosomal abnormalities from the 10th week of pregnancy. A safe alternative to amniocentesis. Chromosome 13, 18, 21 trisomy, sex chromosome aneuploidy, triploidy.

€390

Diagnostics

Thrombophilia DNA Test

Genetic test for assessment of the risk of thrombophilia.

€119

Diagnostics

Fetal rhesus factor (RhD) DNA test from the mother's blood (from the 11th week of pregnancy)

Fetal rhesus factor detection from the mother's blood – non-invasive test from the 11th week of pregnancy.

€185

Diagnostics

Fetal sex determination from the mother's blood (from the 11th week of pregnancy)

Fetal sex determination from the mother's blood is an accurate non-invasive test which can be performed from the 11th week of pregnancy. It is possible to choose the recipient of the result for the organization of gender reveal celebrations.

€185

Diagnostics

Testing for determination of the risk of hereditary breast and ovarian cancer (BRCA1)

BRCA1 gene mutation screening to assess the risk of hereditary breast and ovarian cancer. A simple blood test with a fundamental role in cancer prevention.

€109

Diagnostics

IVF pregnancy non-invasive prenatal test (NIPT) -'Panorama' (from the 10th week of pregnancy)

Non-invasive prenatal test from the mother's blood, which determines the risk of chromosomal abnormalities from the 10th week of pregnancy. A safe alternative to amniocentesis. Trisomy of chromosomes 13, 18, 21; aneuploidy of sex chromosomes; triploidy.

€390

Diagnostics

GenEra NIPT “Panorama” test, medium

Non-invasive prenatal test from maternal blood, which determines the risk of chromosomal abnormalities as early as from the 10th week of pregnancy. A safe alternative to amniocentesis. Chromosome 13, 18, 21 trisomy, sex chromosome aneuploidy, triploidy + 22q11.2 chromosomal deletion (Di George syndrome).

€475

Diagnostics

Gen Era NIPT “Panorama” test, extended

Non-invasive prenatal test from maternal blood, which determines the risk of chromosomal abnormalities as early as the 10th week of pregnancy. A safe alternative to amniocentesis. Chromosome 13, 18, 21 trisomy, sex chromosome aneuploidy, triploidy + microdeletions: 22q11.2 (Di Georges syndrome), 1p36 deletion syndrome, Angelman syndrome, Prader-Willi syndrome, Cri-du-chat syndrome.

€525

Home

Services